CD40 Agonists Alter the Pancreatic Cancer Microenvironment by Shifting the Macrophage Phenotype toward M1 and Suppress Human Pancreatic Cancer in Organotypic Slice Cultures-Reference-Cited by-同舟云学术

CD40 Agonists Alter the Pancreatic Cancer Microenvironment by Shifting the Macrophage Phenotype toward M1 and Suppress Human Pancreatic Cancer in Organotypic Slice Cultures

Published:2021-12-21 Issue: Volume: Page:
ISSN:1976-2283
Container-title:Gut and Liver
language:en
Short-container-title:Gut and Liver

Author:

Lim Chae Yoon¹^ORCID,Chang Jae Hyuck²^ORCID,Lee Won Sun¹^ORCID,Kim Jeana³^ORCID,Park Il Young⁴^ORCID

Affiliation:

1. Institute of Clinical Medicine Research, The Catholic University of Korea, Seoul, Korea

2. Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea

3. Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea

4. Department of Surgery, College of Medicine, The Catholic University of Korea, Seoul, Korea

Funder

Bucheon St. Mary’s Hospital

Ministry of Education

Publisher

The Editorial Office of Gut and Liver

Subject

Gastroenterology,Hepatology

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiogenesis and Pancreatic Cancer: Novel Approaches to Overcome Treatment Resistance;Current Cancer Drug Targets;2024-11

2. Biological Barriers for Drug Delivery and Development of Innovative Therapeutic Approaches in HIV, Pancreatic Cancer, and Hemophilia A/B;Pharmaceutics;2024-09-13

3. Roles of M1 Macrophages and Their Extracellular Vesicles in Cancer Therapy;Cells;2024-08-26

4. Promising first results of mitazalimab in metastatic pancreatic ductal adenocarcinoma;Medicom Conference Report ESMO GI 2024;2024-08-21

5. Small steps can lead to substantial breakthroughs: moving the therapeutic needle forward in pancreatic cancer;The Lancet Oncology;2024-07